Concepedia

Catherine Chang

CC

Statistics

Publications

22

Citations

2.2K

H-Index

18

Active since

2007

Affiliations

The University of Melbourne(Current)

Walter and Eliza Hall Institute of Medical Research

The Royal Melbourne Hospital

Monash University

University of Birmingham

Catherine Chang is an author at The University of Melbourne specializing in apoptosis, life sciences, and oncology.

Publications per year

2007–2024

22

Publications

22

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

András Kotschy, Zoltán Szlávik, James B. Murray et al. · Nature · 2016 · 1.1K citations

Medicine, Oncology, Pharmacology +11

VDAC2 enables BAX to mediate apoptosis and limit tumor development

Hui San Chin, Xiang Li, Iris K. L. Tan et al. · Nature Communications · 2018 · 192 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias

Rachel Thijssen, Sarah T. Diepstraten, Donia M. Moujalled et al. · Blood · 2021 · 135 citations · Full text

Medicine, Cancer Biology, Oncology +12

Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells

Zilu Wang, Matteo Burigotto, Sabrina Ghetti et al. · Cancer Discovery · 2023 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +15

Humanized Mcl-1 mice enable accurate preclinical evaluation of MCL-1 inhibitors destined for clinical use

Margs S. Brennan, Catherine Chang, Lin Tai et al. · Blood · 2018 · 89 citations · Full text

Medicine, Pharmacology, Cancer Pharmacology +4

1–5 of 22